Eric P. Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eric P. Smith has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Doug Winstanley
Dermatology Department, Naval Medical Center San Diego, San Diego, California
2 shared publicationsBradley S Graham
1 shared publication- Christina A. Hardaway
Department of Dermatology, Naval Medical Center San Diego, California 92134-5000, USA
1 shared publication E. Victor Ross
Dermatology Department, Naval Medical Center San Diego, San Diego, California
1 shared publicationE.VIctor Ross
Dermatology Department, Naval Medical Center San Diego, San Diego, California
1 shared publicationPeter A S Johnstone
1 shared publication
Latest Publications
- 1 September 2006
- Vol. 78 (3) , 162-4
Folliculitis decalvans treated with radiation therapy.
A 33-year-old black man presented with folliculitis decalvans resistant to multiple oral and topical therapies. The patient ultimately responded to radiation therapy.
- 1 September 2006
- Vol. 78 (3) , 162-4
Folliculitis decalvans treated with radiation therapy.
A 33-year-old black man presented with folliculitis decalvans resistant to multiple oral and topical therapies. The patient ultimately responded to radiation therapy.
- 21 March 2006
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 31 (3) , 297-301
Modified Superlong Pulse 810 nm Diode Laser in the Treatment of Pseudofolliculitis Barbae in Skin Types V and VI
Laser hair removal is a well-established therapy for pseudofolliculitis barbae, but there have been few studies on the use of a very-long-pulse 810 nm diode laser for this condition. To determine the efficacy and tolerability of a modified 810 nm superlong-pulse diode laser (Palomar Medical, Burlington, MA, USA) in the treatment of pseudofolliculitis barbae (PFB) in subjects with type V and VI skin. Thirteen patients were treated three times at 2-week intervals on one side of their neck with varying fluences. They were evaluated for (1) reduction of shaving bumps and (2) pain tolerance on the treated versus the untreated side. There was a statistically significant improvement in shaving bumps. The treatment side showed a baseline PFB lesion count of 22.5 (+/- 20 SD), which decreased to a mean of 5 (+/- 5 SD) (p<.05). The control baseline mean count was 27.6 (+/- 22 SD) and at the end of the study was 15 (+/- 12 SD) (p = .13). Pain was rated at 2.5 of 10 for subjects treated both with and without anesthetic. The margin of safety was greater in type V compared with type VI skin. A modified 810 nm superlong-pulse diode laser is both effective and well tolerated in the reduction of shaving bumps, especially in patients with type V skin.
- 21 March 2006
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 31 (3) , 297-301
Modified Superlong Pulse 810 nm Diode Laser in the Treatment of Pseudofolliculitis Barbae in Skin Types V and VI
Laser hair removal is a well-established therapy for pseudofolliculitis barbae, but there have been few studies on the use of a very-long-pulse 810 nm diode laser for this condition. To determine the efficacy and tolerability of a modified 810 nm superlong-pulse diode laser (Palomar Medical, Burlington, MA, USA) in the treatment of pseudofolliculitis barbae (PFB) in subjects with type V and VI skin. Thirteen patients were treated three times at 2-week intervals on one side of their neck with varying fluences. They were evaluated for (1) reduction of shaving bumps and (2) pain tolerance on the treated versus the untreated side. There was a statistically significant improvement in shaving bumps. The treatment side showed a baseline PFB lesion count of 22.5 (+/- 20 SD), which decreased to a mean of 5 (+/- 5 SD) (p<.05). The control baseline mean count was 27.6 (+/- 22 SD) and at the end of the study was 15 (+/- 12 SD) (p = .13). Pain was rated at 2.5 of 10 for subjects treated both with and without anesthetic. The margin of safety was greater in type V compared with type VI skin. A modified 810 nm superlong-pulse diode laser is both effective and well tolerated in the reduction of shaving bumps, especially in patients with type V skin.
- 1 March 2005
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 31 (3) , 297-301
Modified Superlong Pulse 810 nm Diode Laser in the Treatment of Pseudofolliculitis Barbae in Skin Types V and VI
Background Laser hair removal is a well-established therapy for pseudofolliculitis barbae, but there have been few studies on the use of a very-long-pulse 810 nm diode laser for this condition. Objective To determine the efficacy and tolerability of a modified 810 nm superlong-pulse diode laser (Palomar Medical, Burlington, MA, USA) in the treatment of pseudofolliculitis barbae (PFB) in subjects with type V and VI skin. Methods Thirteen patients were treated three times at 2-week intervals on one side of their neck with varying fluences. They were evaluated for (1) reduction of shaving bumps and (2) pain tolerance on the treated versus the untreated side. Results There was a statistically significant improvement in shaving bumps. The treatment side showed a baseline PFB lesion count of 22.5 (±20 SD), which decreased to a mean of 5 (±5 SD) (p < .05). The control baseline mean count was 27.6 (±22 SD) and at the end of the study was 15 (±12 SD) (p= .13). Pain was rated at 2.5 of 10 for subjects treated both with and without anesthetic. The margin of safety was greater in type V compared with type VI skin. Conclusion A modified 810 nm superlong-pulse diode laser is both effective and well tolerated in the reduction of shaving bumps, especially in patients with type V skin.
- 1 March 2005
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 31 (3) , 297-301
Modified Superlong Pulse 810 nm Diode Laser in the Treatment of Pseudofolliculitis Barbae in Skin Types V and VI
Background Laser hair removal is a well-established therapy for pseudofolliculitis barbae, but there have been few studies on the use of a very-long-pulse 810 nm diode laser for this condition. Objective To determine the efficacy and tolerability of a modified 810 nm superlong-pulse diode laser (Palomar Medical, Burlington, MA, USA) in the treatment of pseudofolliculitis barbae (PFB) in subjects with type V and VI skin. Methods Thirteen patients were treated three times at 2-week intervals on one side of their neck with varying fluences. They were evaluated for (1) reduction of shaving bumps and (2) pain tolerance on the treated versus the untreated side. Results There was a statistically significant improvement in shaving bumps. The treatment side showed a baseline PFB lesion count of 22.5 (±20 SD), which decreased to a mean of 5 (±5 SD) (p < .05). The control baseline mean count was 27.6 (±22 SD) and at the end of the study was 15 (±12 SD) (p= .13). Pain was rated at 2.5 of 10 for subjects treated both with and without anesthetic. The margin of safety was greater in type V compared with type VI skin. Conclusion A modified 810 nm superlong-pulse diode laser is both effective and well tolerated in the reduction of shaving bumps, especially in patients with type V skin.